bromodeoxyuridine has been researched along with Ewing Sarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldini, N; Benini, S; Cerisano, V; Lollini, PL; Manara, MC; Mercuri, M; Nanni, P; Picci, P; Scotlandi, K | 1 |
Iwai, M; Kosuga, M; Miyahira, Y; Ohta, S; Okabe, H; Shimada, M; Sugiura, Y; Suzuki, A; Suzuki, S; Taga, T | 1 |
2 other study(ies) available for bromodeoxyuridine and Ewing Sarcoma
Article | Year |
---|---|
Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Nucleus; Dose-Response Relationship, Drug; Doxorubicin; Humans; Receptor, IGF Type 1; Sarcoma, Ewing; Suramin; Tumor Cells, Cultured; Vincristine | 2001 |
Neuronal differentiation of Ewing's sarcoma induced by cholera toxin B and bromodeoxyuridine--establishment of Ewing's sarcoma cell line and histochemical study.
Topics: Antigens, Differentiation; Bromodeoxyuridine; Cell Differentiation; Child; Cholera Toxin; Humans; Intermediate Filaments; Male; Neurons; S100 Proteins; Sarcoma, Ewing; Tumor Cells, Cultured | 1991 |